CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer

Swarupananda Mukherjee, Dipanjan Karati, Sinjini Sarkar, Dipanjana Ash, Shayeri Chatterjee Ganguly, Ayon Dutta, Rajesh Kesarla

Open source

DOI
10.1080/17435889.2026.2732014
Published
2026-09-10
Container
Nanomedicine
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/17435889.2026.2732014,
  title = {CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer},
  author = {Swarupananda Mukherjee and Dipanjan Karati and Sinjini Sarkar and Dipanjana Ash and Shayeri Chatterjee Ganguly and Ayon Dutta and Rajesh Kesarla},
  year = {2026},
  journal = {Nanomedicine},
  doi = {10.1080/17435889.2026.2732014},
  url = {https://doi.org/10.1080/17435889.2026.2732014}
}

RIS

TY  - JOUR
TI  - CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
AU  - Swarupananda Mukherjee
AU  - Dipanjan Karati
AU  - Sinjini Sarkar
AU  - Dipanjana Ash
AU  - Shayeri Chatterjee Ganguly
AU  - Ayon Dutta
AU  - Rajesh Kesarla
PY  - 2026
JO  - Nanomedicine
DO  - 10.1080/17435889.2026.2732014
UR  - https://doi.org/10.1080/17435889.2026.2732014
ER  - 

APA

Mukherjee, S., Karati, D., Sarkar, S., Ash, D., Ganguly, S. C., Dutta, A., & Kesarla, R. (2026). CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer. Nanomedicine. https://doi.org/10.1080/17435889.2026.2732014

Source records